Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vincent W. Keng"'
Autor:
Eunice Y. Lau, Man Tong, Katherine Po Sin Chung, Terence K. Lee, Stephanie Ma, Rainbow Wing Hei Leung, Etienne H. Mok, Irene Oi-Lin Ng, Martina Mang Leng Lei, Q Zhao, Vincent W. Keng, Carmen Oi Ning Leung, Hoi Wing Leung, Cong Ma
Publikováno v:
Cancer Research. 81:3229-3240
The survival benefit derived from sorafenib treatment for patients with hepatocellular carcinoma (HCC) is modest due to acquired resistance. Targeting cancer stem cells (CSC) is a possible way to reverse drug resistance, however, inhibitors that spec
Autor:
Lewis R. Roberts, Robert Hullsiek, Lindsey A. Lee, Wendy A. Hudson, Barbara R. Tschida, Timothy P. Kuka, Michael A. Linden, Vincent W. Keng, Sandra Wagner, David A. Largaespada, Rachel A. Heuer, Pauline J. Beckmann, Nuri A. Temiz, Khalid Amin, Jesse D. Riordan, Joseph H. Nadeau, Ju Dong Yang, Adam J. Dupuy, Carlos A. Tierrablanca, Aaron L. Sarver
Publikováno v:
Cancer Research. 77:6576-6588
Hepatic steatosis is a strong risk factor for the development of hepatocellular carcinoma (HCC), yet little is known about the molecular pathology associated with this factor. In this study, we performed a forward genetic screen using Sleeping Beauty
Autor:
Adam J. Dupuy, Barbara R. Tschida, Vincent W. Keng, David A. Largaespada, Khalid Amin, Christopher S. Stipp, Pauline J. Beckmann, Charlotte R. Feddersen, Michael A. Linden, Jesse D. Riordan
Most hepatocellular carcinomas (HCCs) develop in a chronically injured liver, yet the extent to which this microenvironment promotes neoplastic transformation or influences selective pressures for genetic drivers of HCC remains unclear. We sought to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e536d52d60f1ab77cc1c53064e4ec808
https://europepmc.org/articles/PMC5826818/
https://europepmc.org/articles/PMC5826818/
Autor:
Lilian H. Lo, David A. Largaespada, Barbara R. Tschida, Amy P. Chiu, Dewi K Rowlands, Branden S. Moriarity, Vincent W. Keng
Publikováno v:
World Journal of Gastroenterology. 21:12157
The major type of human liver cancer is hepatocellular carcinoma (HCC), and there are currently many risk factors that contribute to this deadly disease. The majority of HCC occurrences are associated with chronic hepatitis viral infection, and hepat
Publikováno v:
Journal of Hepatology. 57(2):453-454
Despite recent breakthroughs in the management of hepatocellular carcinoma (HCC), it is still the fastest-rising cause of cancer-related death in the United States [1]. Unfortunately, most patients are diagnosed at intermediate-advanced stages, when